Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis (STARS Trial)

NCT07332325 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT07332325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07332325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis (STARS Trial)
Lead sponsor
University of Virginia
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
September 30, 2029
Enrollment
344 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, tuberculosis